Document is current
Any future updates will be listed below
-
Authors
Rinott, Ehud
Meir, Anat Yaskolka
Tsaban, Gal
Zelicha, Hila
Kaplan, Alon
Knights, Dan
Tuohy, Kieran
Scholz, Matthias Uwe
Koren, Omry
Stampfer, Meir J.
Wang, Dong D.
Shai, Iris
Youngster, Ilan https://orcid.org/0000-0001-5233-1213
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (209933838)
Rosetrees Trust (A2623)
Israel Ministry of Health (87472511)
Ministry of Science and Technology, Israel (3-13604)
California Walnuts Commission
European Commission JPI-HDHL project (31965/7303/16)
ERA-Net Cofund ERA-HDHL (N696295)
- License Information
-
More Information
Article History
Received: 29 April 2021
Accepted: 24 January 2022
First Online: 10 March 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Medical Ethics Board and Institutional Review Board at Soroka University Medical Centre, Be’er Sheva, Israel (SOR-0280-16). Participants provided written informed consent and received no compensation.This trial was registered at ClinicalTrials.gov (NCT03020186). The research was conducted in strict compliance with the Helsinki Declaration.
: Not applicable.
: IY is an advisor for Mybiotics Ltd. IS advises the nutritional committee of Hinoman, Ltd.DK serves as Senior Scientific Advisor to Diversigen, Inc. The remaining authors declare that they do not have any competing interests.
